-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imatinib Mesylate in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imatinib Mesylate in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drug Details: Imatinib mesylate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CYT-107 in Sepsis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CYT-107 in Sepsis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CYT-107 in SepsisDrug Details:CYT-107 is under development for coronavirus disease 2019 caused by the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CYT-107
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CYT-107 Drug Details CYT-107 is under development for coronavirus disease 2019 caused by the...
-
Product Insights
Progressive Multifocal Leukoencephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain caused by lytic infection of oligodendrocytes by the JC polyomavirus. Its symptoms include clumsiness, progressive weakness, and visual, speech, and sometimes personality changes. The PML pipeline market research report provides comprehensive information on the therapeutics under development for PML, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...